An informational overview examining what consumers often consider when researching telehealth-based prescription weight ...

Semaglutide is not the only medication in this drug class. Eli Lilly has developed its own GLP-1 receptor agonist, ...

Sun said India's drug regulator has approved it to manufacture and market semaglutide injections for chronic weight ...

India-EU FTA to lower tariffs on pharma, potentially making GLP-1 therapies like semaglutide cheaper and boosting adoption among diabetics in India ...

By Amina Niasse NEW YORK, Jan 28 (Reuters) - Telehealth company Ro has had an influx of new customers seeking the newly ...

Hims & Hers is a Strong Buy, as shares appear historically cheap due to temporary margin compression and regulatory concerns.

More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro ...

A booming black market in weight-loss injections exposes desperate patients to serious health and legal risks.

Telehealth company Ro is witnessing high demand for its new weight loss pill, Wegovy, especially among men who preferred pills over injections. Ro's strategic Super Bowl advertising, featuring Serena ...

New Jersey ranks as the 13th healthiest state, boasting a low smoking rate, active lifestyle, and improving air quality, ...

However, concerns about the impact of rapid glycemic control on diabetic retinopathy risk ...

Eye-stroke, vomiting and burst colon: Lawsuits accuse weight-loss drugs of severe side effects - Thousands of patients have ...